Current Insights into the Role of the Growth Hormone-Insulin-Like Growth Factor System in Short Children Born Small
Judith S Renes1, Jaap van Doorn2, Anita C S Hokken-Koelega3,4
1Department of Paediatrics, Subdivision of Endocrinology, Erasmus University Medical Centre, Sophia Children's Hospital, Rotterdam, The Netherlands, j.renes@erasmusmc.nl.
Insights
Growth hormone (GH) and insulin-like growth factor (IGF) axis issues may explain why some babies born small for gestational age (SGA) don't catch up in growth. Reduced IGF-I activity in utero and after birth is implicated.
Area of Science:
- Pediatric endocrinology
- Growth disorders
- Molecular genetics
Background:
- 10% of infants born small for gestational age (SGA) exhibit insufficient catch-up growth.
- The underlying mechanisms for this growth failure are not fully understood.
- Disruptions in the growth hormone (GH)-insulin-like growth factor (IGF) axis are suspected contributors.
Purpose of the Study:
- To review molecular and genetic mechanisms of the GH-IGF axis in short children born SGA.
- To elucidate the role of IGF system anomalies in SGA growth failure.
Main Methods:
- Review of existing literature on GH-IGF axis in SGA.
- Analysis of molecular and (epi)genetic factors.
- Examination of IGF-I, IGF-binding proteins (IGFBP), and related components.
Main Results:
- Lowered IGF-I levels in cord blood and placenta of SGA neonates.
- Increased placental expression of IGFBP-1 and IGFBP-2, inhibiting IGF-I bioactivity.
- Sustained reduced IGF-I, IGFBP-3, and acid-labile subunit levels in short SGA children.
- Evidence of increased IGFBP-3 proteolysis.
Conclusions:
- Suggests decreased in utero IGF-I bioactivity in SGA neonates.
- Highlights persistent IGF-I axis dysregulation in SGA children with short stature.
- Points to specific molecular anomalies within the IGF system as key factors in SGA growth failure.
Background:
The reason for the insufficient catch-up growth seen in 10% of children born small for gestational age (SGA) is poorly understood. Disturbances in the growth hormone (GH) - insulin-like growth factor (IGF) axis might underlie this failure to show sufficient catch-up growth.
Conclusion:
This review summarizes insights gained in the molecular and (epi) genetic mechanisms of the GH-IGF axis in short children born SGA. The most notable anomalies of the IGF system are the lowered IGF-I levels in both cord blood and the placenta, and the increased expression of IGF-binding proteins (IGFBP)-1 and IGFBP-2, which inhibit IGF-I, in the placenta of SGA neonates. These observations suggest a decreased bioactivity of IGF-I in utero. IGF-I levels remain reduced in SGA children with short stature, as well as IGFBP-3 and acid-labile subunit levels. Proteolysis of IGFBP-3 appears to be increased.
Related Concept Videos
Role of Hematopoietic Growth Factors
Thrombopoietin (TPO), mainly released by the liver,...
06:36A Modified In vitro Invasion Assay to Determine the Potential Role of Hormones, Cytokines and/or Growth Factors in Mediating Cancer Cell Invasion
Population Growth
05:56Demonstrating a Linear Relationship Between Vascular Endothelial Growth Factor and Luteinizing Hormone in Kidney Cortex Extracts
05:28Determining a Test Growth Hormone Effect on Kisspeptin Neurons using a Whole-Cell Patch Clamp
06:35A Mouse Model to Investigate the Role of Cancer-Associated Fibroblasts in Tumor Growth

